The TMCTA is a coalition of Tennesseans advocating for legalization of medical cannabis in Tennessee. We are opposed to the legalization of cannabis for recreational purposes.
Our mission is to provide a legal, transparent, safe, and accessible business environment to grow, process, and dispense medical cannabis to relieve the pain and suffering of medical patients.
The TMCTA Board Welcomes New Board Member Dan Pabon
Dan served eight years in the Colorado Legislature. He served in House leadership for seven years as Deputy Whip, Assistant Majority Leader, Speaker Pro Tempore, and Chair of the House Finance Committee.
- Appointed in 2012 by the Governor to serve on the Amendment 64 committee, overseeing implementation of Colorado’s marijuana laws.
- Chaired the regulatory framework working group which established the first regulated cannabis system in the world. - Chaired the Joint Select Committee on the Implementation of Amendment 64.
- Sponsored the first three bills that put the cannabis system into law.
Mr. Pabon has since worked on dozens of enhancements to the model that have been adopted by most jurisdictions in the U.S., Canada, and internationally.
Where Marijuana is Legal, Opioid Prescriptions Fall
Two new studies support this correlation
“In this time when we are so concerned—rightly so—about opiate misuse and abuse and the mortality that’s occurring, we need to be clear-eyed and use evidence to drive our policies,” said W. David Bradford, an economist at the University of Georgia and an author of one of the studies. “If you’re interested in giving people options for pain management that don’t bring the particular risks that opiates do, states should contemplate turning on dispensary-based cannabis policies.”
Utah has a new medical marijuana law — but not the one approved by voters in the recent election
On Monday, the first business day after Utah’s medical cannabis initiative became law, state legislators supplanted it with a more tightly controlled plan for providing marijuana-based treatment. Utah Governor Gary Herbert said he’s committed to implementing the legislation as quickly as possible.
STUDY SHOWS: Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
A study published by the National Institute of Health: “We conducted a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis in subjects, the majority of whom were experiencing neuropathic pain despite traditional treatment. Thirty-nine patients with central and peripheral neuropathic pain underwent a standardized procedure for inhaling either medium dose (3.53%), low dose (1.29%), or placebo cannabis with the primary outcome being VAS pain intensity. Psychoactive side effects, and neuropsychological performance were also evaluated.”
Tell us your story
We want to hear from you.